Ahmedabad, Gujarat, India, July 2025 – Manish Kainth has joined Torrent Pharmaceuticals Ltd as the Chief Human Resources Officer (CHRO). In his new role, he will be responsible for leading the company’s HR strategy and initiatives across global operations, focusing on talent transformation, organizational development, and future-ready HR practices.
Prior to joining Torrent Pharmaceuticals, Manish Kainth was with Tata Consumer Products for over 10 years, where he held several leadership roles. Most recently, he served as Senior Vice President – HR, where he led key talent and transformation initiatives. Earlier, he was Head HR for International Business, based in the United Kingdom, and also held positions as Senior Vice President HR, Vice President HR, and GM-HR, contributing to the growth of global talent programs and business HR alignment.
Before his tenure at Tata Consumer Products, Manish worked at GlaxoSmithKline Consumer Healthcare as GM – Human Resources, focusing on talent management, leadership development, and organizational capability building.
He also held the position of Vice President – Human Resources at HSBC, and earlier served as GM-HR at IBM, where he led strategic HR functions in a dynamic technology environment.
Manish began his HR journey at Hindustan Unilever Limited, where he spent over six years in factory and branch HR roles. He started his career as an Engineer at Tata Motors, giving him a strong foundation in operations before transitioning to HR leadership.
About Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is the flagship company of the Torrent Group, with a consolidated annual revenue exceeding INR 10,700 crores. Ranked among the top five pharma companies in the Indian market, Torrent Pharma has a significant presence in therapeutic segments including Cardiovascular, CNS, Gastrointestinal, VMN, and Cosmo-Dermatology, with expanding operations in diabetology, oncology, and anti-infectives.
The company operates 8 manufacturing plants, 5 of which are USFDA approved, and employs around 800 scientists in its R&D centers. Torrent has a strong international footprint, particularly in Germany and Brazil, and continues to grow through strategic acquisitions including Elder Pharma, Zyg Pharma, Glochem Industries, and the Indian branded businesses of Novartis and Unichem.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
